3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Colonic Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
pembrolizumab
8
Oxaliplatin
7
Surveys and Questionnaires
5
Methods
5
Early Intervention, Educational
5
Cyclophosphamide
5
Cisplatin
5
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Gemcitabine
4
Fluorouracil
4
Carboplatin
4
veliparib
3
aldesleukin
3
Trastuzumab
3
Specimen Handling
3
Nivolumab
3
Diathermy
3
Cytoreduction Surgical Procedures
3
sargramostim
2
entinostat
2
cemiplimab
2
cediranib
2
X-Rays
2
Therapeutics
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Metformin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Doxycycline
×
Gynecologic
×
Clear all
NCT02201381
2022-07-18
METRICS
Health Clinics Limited
Phase 3
Withdrawn